Related references
Note: Only part of the references are listed.Diverse Immunomodulatory Effects of Individual IFNα Subtypes on Virus-Specific CD8+ T Cell Responses
Julia Dickow et al.
FRONTIERS IN IMMUNOLOGY (2019)
Adjuvant interferon-α for the treatment of high-risk melanoma: An individual patient data meta-analysis
Natalie J. Ives et al.
EUROPEAN JOURNAL OF CANCER (2017)
Type-I-interferons in infection and cancer: Unanticipated dynamics with therapeutic implications
Martina Musella et al.
ONCOIMMUNOLOGY (2017)
Type 1 Interferons Potentiate Human CD8+ T-Cell Cytotoxicity Through a STAT4-and Granzyme B-Dependent Pathway
Brittney N. Newby et al.
DIABETES (2017)
Precision Tumor Recognition by T Cells With Combinatorial Antigen-Sensing Circuits
Kole T. Roybal et al.
CELL (2016)
Interferon Alpha Subtype-Specific Suppression of HIV-1 Infection In Vivo
Kerry J. Lavender et al.
JOURNAL OF VIROLOGY (2016)
Nivolumab in Previously Untreated Melanoma without BRAF Mutation
Caroline Robert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
T cell exclusion, immune privilege, and the tumor microenvironment
Johanna A. Joyce et al.
SCIENCE (2015)
Cross-presentation of cutaneous melanoma antigen by migratory XCR1+CD103- and XCR1+CD103+ dendritic cells
Ben Wylie et al.
ONCOIMMUNOLOGY (2015)
Regulation of antiviral T cell responses by type I interferons
Josh Crouse et al.
NATURE REVIEWS IMMUNOLOGY (2015)
STING-Dependent Cytosolic DNA Sensing Mediates Innate Immune Recognition of Immunogenic Tumors
Seng-Ryong Woo et al.
IMMUNITY (2014)
Type I Interferon Signaling Enhances CD8+ T Cell Effector Function and Differentiation during Murine Gammaherpesvirus 68 Infection
Ryan N. Jennings et al.
JOURNAL OF VIROLOGY (2014)
Cancer cell-autonomous contribution of type I interferon signaling to the efficacy of chemotherapy
Antonella Sistigu et al.
NATURE MEDICINE (2014)
Immune Cell-Poor Melanomas Benefit from PD-1 Blockade after Targeted Type I IFN Activation
Tobias Bald et al.
CANCER DISCOVERY (2014)
Human Interferon Alpha-2b: A Therapeutic Protein for Cancer Treatment
Ratih Asmana Ningrum
SCIENTIFICA (2014)
IFN- subtypes: distinct biological activities in anti-viral therapy
K. Gibbert et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
The Efficacy of Radiotherapy Relies upon Induction of Type I Interferon-Dependent Innate and Adaptive Immunity
Byron C. Burnette et al.
CANCER RESEARCH (2011)
Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T-Cell Transfer Immunotherapy
Steven A. Rosenberg et al.
CLINICAL CANCER RESEARCH (2011)
Binding and activity of all human alpha interferon subtypes
Thomas B. Lavoie et al.
CYTOKINE (2011)
Host type I IFN signals are required for antitumor CD8+ T cell responses through CD8α+ dendritic cells
Mercedes B. Fuertes et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Type I interferon is selectively required by dendritic cells for immune rejection of tumors
Mark S. Diamond et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Evolutionary genetic dissection of human interferons
Jeremy Manry et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Targeted delivery of interferon-alpha via fusion to anti-CD20 results in potent antitumor activity against B-cell lymphoma
Caiyun Xuan et al.
BLOOD (2010)
Tumor-targeted interferon-α delivery by Tie2-expressing monocytes inhibits tumor growth and metastasis
Michele De Palma et al.
CANCER CELL (2008)
Cutting edge: Enhancement of antibody responses through direct stimulation of B and T cells by type IIFN
A Le Bon et al.
JOURNAL OF IMMUNOLOGY (2006)
A critical function for type I interferons in cancer immunoediting
GP Dunn et al.
NATURE IMMUNOLOGY (2005)
Characterization of the murine alpha interferon gene family
V van Pesch et al.
JOURNAL OF VIROLOGY (2004)
Characterization of the type I interferon locus and identification of novel genes
MP Hardy et al.
GENOMICS (2004)
Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon
A Le Bon et al.
NATURE IMMUNOLOGY (2003)
Type I interferon differential therapy for erythroleukemia: specificity of STAT activation
VS Cull et al.
BLOOD (2003)
Type I interferon gene therapy protects against cytomegalovirus-induced myocarditis
VS Cull et al.
IMMUNOLOGY (2002)
IFN-α/β enhances BCR-dependent B cell responses
D Braun et al.
INTERNATIONAL IMMUNOLOGY (2002)
Characterization of two TCR transgenic mouse lines specific for herpes simplex virus
SN Mueller et al.
IMMUNOLOGY AND CELL BIOLOGY (2002)
IFN-α-expressing tumor cells enhance generation and promote survival of tumor-specific CTLs
K Hiroishi et al.
JOURNAL OF IMMUNOLOGY (2000)
Share Paper
